Skip to main content
OpenTrials

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,109 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Active, Not Recruiting

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma

NCT05315258

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust (Screening only) Cambridge, United Kingdom
  • The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • The Clatterbridge Cancer Centre Liverpool, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Active, Not Recruiting

Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

NCT06640530

Conditions
Advanced Melanoma, Melanoma, Melanoma (Skin), +11 more
Locations
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Republic Scientific and Practical Centre for Oncology and Medical Radiology Named after N.N.Aleksandrov" Minsk, Belarus
View all 44 locations
View Trial Details
Active, Not Recruiting

A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma

NCT05751928

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +12 more
Locations
  • State Institution "Republican Scientific and Practical Center of Oncology and Medical Radiology named after A.I. N.N. Alexandrov" Lesnoy, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Mogilev Regional Oncological Dispensary" Mogilev, Belarus
  • Healthcare Institution "Vitebsk Regional Clinical Oncology Center" Vitebsk, Belarus
View all 36 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2 Study of BA3071 in Patients With Solid Tumors

NCT05180799

Conditions
Melanoma, NSCLC, Neoplasm Metastasis, +14 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Piedmont West Atlanta, Georgia, United States
  • Northwest Cancer Centers Dyer, Indiana, United States
View Trial Details
Active, Not Recruiting

Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma

NCT02743819

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Mount Sinai Medical Center of Florida Miami Beach, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details

Related conditions